Steven Cohen’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.86M Sell
345,402
-827,994
-71% -$11.5M ﹤0.01% 2199
2026
Q2
$14.9M Buy
+1,173,396
New +$9.8M 0.02% 1042
2024
Q4
– Sell
-76,685
Closed -$3.42M – 2528
2024
Q3
$3.42M Buy
+76,685
New +$2.82M 0.01% 986
2020
Q3
– Sell
-8,226
Closed -$2.25M – 1130
2020
Q2
$2.25M Buy
+8,226
New +$2.19M 0.01% 576
2019
Q3
– Sell
-11,344
Closed -$4M – 1522
2019
Q2
$4M Buy
+11,344
New +$4.46M 0.02% 552

Other funds holding QTTB

Steven Cohen's QTTB Position: Q3 2026 in Review

Steven Cohen reduced its Q32 Bio (QTTB) stake by 71% in Q3 2026, selling an estimated $11.5M and leaving 345,402 shares worth $2.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

Steven Cohen first reported a position in QTTB in Q2 2019 and has held it in 5 quarters since. The position peaked at $14.9M in Q2 2026. 106 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

  • Steven Cohen held 345,402 shares of Q32 Bio worth $2.86M as of Q3 2026.
  • Steven Cohen sold 827,994 Q32 Bio shares in Q3 2026, an estimated $11.5M.
  • Q32 Bio made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2199 holding.
  • Steven Cohen first reported a position in Q32 Bio in Q2 2019 and has held it in 5 quarters since.
  • Steven Cohen's Q32 Bio position peaked at $14.9M in Q2 2026.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.